What alternative contraceptive options are suitable for a patient with a history of intracranial hypertension, migraine with aura, and severe stabbing pain around ovulation, who is currently taking progesterone-only pills (POP) and has a history of two cesarean sections (C-sections) and an appendectomy?

Alternative Contraception for Patient with Intracranial Hypertension and Migraine with Aura

You should switch this patient to a levonorgestrel-releasing intrauterine device (IUD), which provides highly effective contraception while avoiding the absolute contraindication of estrogen in migraine with aura and may reduce her ovulation-related pain. 1

Why Combined Hormonal Contraceptives Are Absolutely Contraindicated

• Combined hormonal contraceptives are absolutely contraindicated in women with migraine with aura regardless of any association with their menstrual cycle, owing to an associated increase in the risk of stroke. 2
• Migraine with aura independently increases stroke risk 2.5-fold (RR 2.51; 95% CI 1.52-4.14), and adding estrogen-containing contraceptives compounds this risk catastrophically. 1
• The 2024 American Heart Association/American Stroke Association guidelines mandate absolute prohibition of estrogen-containing methods in patients with migraine with aura. 3, 1
• Even ultra-low-dose formulations containing less than 20 μg ethinyl estradiol carry unacceptable stroke risk in this population. 3

Recommended Contraceptive Options

First Choice: Levonorgestrel IUD (52 mg)

The levonorgestrel IUD is the optimal choice for this patient because it addresses multiple clinical needs simultaneously. 1

• Contraceptive efficacy: Greater than 99% effectiveness with perfect and typical use. 3
• No stroke risk: Progestin-only methods carry no increased stroke risk and are specifically recommended for patients with multiple stroke risk factors. 4, 1
• Pain management: The levonorgestrel IUD may reduce ovulation-related pain by suppressing ovulation and reducing endometrial prostaglandin production. 1
• Extended duration: FDA-approved for 7 years (Mirena), with evidence supporting safe use up to 7 years. 5
• Surgical history compatibility: Prior cesarean sections and appendectomy do not contraindicate IUD placement. 4

Second Choice: Copper IUD

• Provides highly effective contraception (>99%) without any hormones. 3
• No stroke risk whatsoever. 4, 3
• FDA-approved for 10 years, with evidence supporting safe use up to 12 years. 5
• Caveat: May worsen menstrual bleeding and cramping for several months after insertion, which could be problematic given her pain history. 4

Third Choice: Etonogestrel Subdermal Implant

• Highly effective (>99%) progestin-only method. 3
• No increased stroke risk. 4
• FDA-approved for 3 years, with evidence supporting safe use up to 5 years. 5
• May suppress ovulation and reduce ovulation-related pain. 1
• Caveat: Irregular bleeding is common and may be bothersome. 1

Fourth Choice: Desogestrel Progestin-Only Pill (75 mcg)

• If the patient refuses or cannot tolerate an IUD or implant, desogestrel 75 mcg daily is an acceptable alternative. 6, 7
• Meta-analysis demonstrates that desogestrel POP significantly reduces the number of migraine attacks, migraine days, intensity, duration, and analgesic use in women with both migraine with and without aura. 7
• Effectiveness: Lower than IUD/implant (typical use failure rate approximately 9%), requiring perfect daily adherence. 8, 9
• No increased stroke risk. 6, 10

Options to Avoid

Depot Medroxyprogesterone Acetate (DMPA)

• Not recommended for this patient due to concern regarding thrombogenicity in patients with elevated stroke risk. 4
• The American College of Rheumatology specifically recommends against DMPA in patients with prothrombotic conditions. 4

Standard Progestin-Only Pills (Norethindrone)

• Less effective than desogestrel at suppressing ovulation. 6
• Typical use failure rate approximately 9%, requiring perfect adherence. 3
• May not provide the migraine benefits seen with desogestrel. 7

Managing Side Effects

Irregular Bleeding with Progestin-Only Methods

• Irregular bleeding patterns are common with all progestin-only methods and should be anticipated. 1
• Can be managed with NSAIDs (ibuprofen 400-600 mg three times daily during bleeding episodes) or short courses of low-dose estrogen if absolutely necessary. 1
• Bleeding patterns typically improve after 3-6 months of use. 1

Addressing Ovulation Pain

• The levonorgestrel IUD and etonogestrel implant both suppress ovulation in many users, which may eliminate ovulation-related pain. 1
• If pain persists despite contraception, consider evaluation for endometriosis or adhesions from prior surgeries. 1

Critical Risk Factor Management

Beyond contraception choice, aggressive management of other stroke risk factors is mandatory in this patient. 1

• Blood pressure monitoring: Screen for and aggressively treat hypertension, as patients with intracranial hypertension may have higher baseline rates. 1
• Tobacco prohibition: Absolute prohibition of tobacco use is necessary, as smoking combined with migraine and any hormonal contraception creates catastrophic stroke risk. 3, 1
• Weight management: Obesity increases both stroke risk and intracranial hypertension severity. 3

Shared Decision-Making Discussion Points

The 2024 AHA/ASA guidelines mandate shared decision-making for patients with stroke risk factors considering contraception. 1

Key points to discuss:

• Absolute contraindication to estrogen-containing methods due to migraine with aura. 2, 1
• Pregnancy-related stroke risk (10-20 per 10,000 woman-years) far exceeds the risk of progestin-only contraception (no increased risk). 4
• IUD placement is safe despite prior abdominal surgeries and does not require routine antibiotic prophylaxis. 4
• Irregular bleeding is common but manageable with progestin-only methods. 1